| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005758607 |
| 005 |
20260326212922.9 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
131130s2013 mau o 000 0 eng d |
| 040 |
|
|
|a YDXCP
|b eng
|e pn
|c YDXCP
|d OCLCO
|d OCLCQ
|d OCLCF
|d EBLCP
|d OPELS
|d N$T
|d DEBSZ
|d OCLCQ
|d D6H
|d OTZ
|d UKBTH
|d OCLCQ
|d VT2
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d EMRUN
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 864414797
|
| 020 |
|
|
|a 9780124077317
|q (electronic bk.)
|
| 020 |
|
|
|a 0124077315
|q (electronic bk.)
|
| 020 |
|
|
|z 9780124077034
|
| 035 |
|
|
|a (OCoLC)900564360
|z (OCoLC)864414797
|
| 050 |
|
4 |
|a QH430
|b .A38 2013
|
| 072 |
|
7 |
|a SCI
|x 027000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 576.5
|2 23
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a Advances in genetics.
|n Volume 84 /
|c edited by, Theodore Friedmann, Jay C. Dunlap, Stephen F. Goodwin.
|
| 250 |
|
|
|a First edition.
|
| 260 |
|
|
|a Waltham, MA :
|b Elsevier Science,
|c 2013.
|
| 300 |
|
|
|a 1 online resource (163 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 520 |
|
|
|a The field of genetics is rapidly evolving, and new medical breakthroughs are occurring as a result of advances in our knowledge of genetics. This series continually publishes important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines.
|
| 588 |
0 |
|
|a Online resource; title from digital title page (viewed on Apr 3, 2014).
|
| 505 |
0 |
|
|a Front Cover; Advances in Genetics; Copyright; Contents; Contributors; Chapter One: Diverse Roles for MAPK Signaling in Circadian Clocks; 1. Circadian Clocks; 1.1. The beginning; 1.2. Organization of the circadian clock; 2. MAPK Signaling Pathways; 2.1. General organization; 2.2. ERK MAPK; 2.3. p38 MAPK; 2.4. JNK MAPK; 3. The Function of MAPKs in Circadian Input Pathways; 3.1. ERK MAPK pathway; 3.2. ERK signaling through downstream components; 3.3. ERK MAPK in peripheral tissues; 3.4. p38 MAPK pathway; 3.5. p38 MAPK in peripheral tissues; 3.6. JNK MAPK pathway; 3.7. Summary
|
| 505 |
8 |
|
|a 4. Endogenous Rhythms in MAPK Activation4.1. ERK in the SCN; 4.2. p38 and JNK MAPK; 4.3. Transcriptional regulation of MAPK components; 4.4. Transcriptional regulation of MAPK components in mammalian peripheral tissue; 4.5. Rhythmic MAPK activity gates input to the circadian clock; 5. MAPKs Modulate the Circadian Oscillator; 5.1. ERK-mediated regulation of the circadian oscillator; 5.2. p38-mediated regulation of the circadian oscillator; 5.3. JNK-mediated regulation of the circadian oscillator; 5.4. Future directions; 6. The Role of MAPK Pathways in Circadian Output; 6.1. ERK MAPK pathway
|
| 505 |
8 |
|
|a 6.2. p38 MAPK pathway6.3. JNK MAPK pathway; 6.4. Future directions; 7. Concluding Remarks; References; Chapter Two: Stakeholder Views on Returning Research Results; 1. Introduction; 2. What is a Research Result?; 3. Guidelines on Returning Research Results; 3.1. Biobanks; 3.2. Population-based studies; 4. Stakeholder Views; 4.1. Researchers; 4.2. IRBs; 4.3. Research participants; 4.3.1. Vulnerable populations: Children; 4.3.2. Underserved minority populations; 4.3.3. Returning research results to relatives of research participants; 5. Extent and Experience with Returning Research Results
|
| 505 |
8 |
|
|a 6. Overall Analysis of Stakeholder Positions6.1. Ethical; 6.2. Legal; 7. Additional Points to Consider; 7.1. Informed consent for returning research results; 7.2. Communication of research results; 7.3. Impact of returning results to affected versus healthy participants; 7.4. Provision of follow-up care; 7.5. Cost; 8. Moving Forward; Acknowledgment; References; Chapter 3: Mouse Models of Radiation-Induced Cancers; 1. Introduction; 2. RI Leukemia; 2.1. RF model; 2.2. SJL/J model; 2.3. C3H model; 2.4. CBA model; 2.5. Underlying molecular pathologies of RI leukemia; 3. RI Lymphoma
|
| 505 |
8 |
|
|a 3.1. C57BL model3.2. BALB/c model; 3.3. NFS model; 3.4. Underlying molecular pathologies of RI lymphoma; 4. RI Lung Cancer; 4.1. C3H model; 4.2. RF model; 4.3. BALB/c model; 4.4. Underlying molecular pathologies of RI lung cancer; 5. RI Breast Cancer; 5.1. BALB/c total body irradiation model; 5.2. BALB/c transplantation model; 5.3. Underlying molecular pathologies of RI breast cancer; 6. Discussion and Conclusions; References; Chapter Four: Genomics of Elite Sporting Performance: What little We Know and Necessary Advances; 1. Introduction
|
| 650 |
|
0 |
|a Genetics.
|
| 650 |
|
6 |
|a Génétique.
|
| 650 |
|
7 |
|a genetics.
|2 aat
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Evolution.
|2 bisacsh
|
| 650 |
|
7 |
|a Genetics
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Friedmann, Theodore,
|d 1935-
|1 https://id.oclc.org/worldcat/entity/E39PBJjxmMfKjgyWvFFkVhppT3
|
| 700 |
1 |
|
|a Dunlap, Jay C.
|1 https://id.oclc.org/worldcat/entity/E39PBJyGVThYxwB8HX66cxxqwC
|
| 700 |
1 |
|
|a Goodwin, Stephen F.
|1 https://id.oclc.org/worldcat/entity/E39PCjHdkqv7mVR7pgJk3YpWwC
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|a Friedmann, Theodore.
|t Advances in Genetics.
|d Burlington : Elsevier Science, ©2013
|z 9780124077034
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/bookseries/00652660/84
|z Connect to the full text of this electronic book
|t 0
|
| 936 |
|
|
|a BATCHLOAD
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i 96356caa-8247-4c0d-9bd5-1d5ff3e56cc9
|s dda8fe15-fc82-4aaf-8b28-d6db1a79896f
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e QH430 .A38 2013
|h Library of Congress classification
|
| 998 |
f |
f |
|a QH430 .A38 2013
|t 0
|l Available Online
|